Blinded by rare disorder, Alberta man fundraising to regain vision
Now a new technology promises to lead him out of the dark. It’s called eSight, electronic glasses for the legally blind. Read more >>
Now a new technology promises to lead him out of the dark. It’s called eSight, electronic glasses for the legally blind. Read more >>
This past month has been nothing short of miraculous in the personal and professional life of K.C. Ryder, a…
read moreCorbus Pharmaceuticals says a Phase 3 clinical trial of anabasum for diffuse cutaneous scleroderma will start in the fourth…
read moreVarioptic is happy to announce that its advanced Caspian module is a part of the recently launched eSight 3,…
read moreThe first patient has been dosed in a Phase 2 study testing NLY01, an investigational compound with a new…
read moreUltracell Insulation, Llc, Limited Liability Company just submitted form D about $850,000 debt financing. This is a new filing….
read moreCorbus Pharmaceuticals Holdings, Inc., a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced…
read moreImageRights International, the world’s leading copyright enforcement service, today announces Andrews McMeel Universal (AMU) will be using its image…
read moreThe student debt crisis is something of a ticking time bomb, and employers are increasingly stepping up by offering…
read moreDan Aziz stood outside of pharmacies surveying pregnant women for market research before starting his company, Luna Pharmaceuticals, which…
read moreSiamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of two posters featuring new…
read more